Historically, this subtype of breast cancer was associated with an increased risk for the development of systemic and brain metastases and poor overall survival The introduction of trastuzumab dramatically changed the outcomes of patients with. The basics about this specific subtype medical journeys is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Systemic (drug) treatments for stage iv breast cancer treatment often continues until the cancer starts growing again or until side effects become unacceptable If this happens, other drugs might be tried The types of drugs used for stage iv breast cancer depend on the hormone receptor status, the her2 status of the cancer, and sometimes gene mutations that might be found
Her2 and metastatic breast cancer the her2 protein is an important driver of cell growth and survival A pathologist determines her2 status by testing a sample of the metastatic tumor (from a biopsy of the metastases)
WATCH
